424 related articles for article (PubMed ID: 31318979)
1. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK
Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
[TBL] [Abstract][Full Text] [Related]
3. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
[TBL] [Abstract][Full Text] [Related]
4. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.
De Rosa R; Palmerini T; De Servi S; Belmonte M; Crimi G; Cornara S; Calabrò P; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Genereux P; Angiolillo D; Piscione F; Galasso G
Int J Cardiol; 2018 May; 259():20-25. PubMed ID: 29579602
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic significance of mean platelet volume/platelet count with GRACE for long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Yu T; Dong Y; Sun Z; Sun Z
Int J Cardiol; 2017 Feb; 228():335-340. PubMed ID: 27866024
[TBL] [Abstract][Full Text] [Related]
6. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
7. Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.
Nozari Y; Parsa M; Jalali A; Ariannejad H; Shafiee A
Arch Iran Med; 2019 Apr; 22(4):198-203. PubMed ID: 31126178
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
Tian C; Song J; He D; Wu J; Sun Z; Sun Z
Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
[TBL] [Abstract][Full Text] [Related]
9. Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
Gager GM; Jilma B; Winter MP; Hengstenberg C; Lang IM; Toma A; Prüller F; Wallner M; Kolesnik E; von Lewinski D; Siller-Matula JM
Eur J Clin Invest; 2020 Nov; 50(11):e13304. PubMed ID: 32506444
[TBL] [Abstract][Full Text] [Related]
10. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
11. Platelet turnover predicts outcome after coronary intervention.
Freynhofer MK; Iliev L; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Huber K
Thromb Haemost; 2017 May; 117(5):923-933. PubMed ID: 28229159
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
Clarkson SA; Heindl B; Cai A; Beasley M; Dillon C; Limdi N; Brown TM
Am J Cardiol; 2021 Jun; 148():1-7. PubMed ID: 33667441
[TBL] [Abstract][Full Text] [Related]
13. White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).
Shah B; Baber U; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916600
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.
Choi SW; Choi DH; Kim HW; Ku YH; Ha SI; Park G
Platelets; 2014; 25(5):322-7. PubMed ID: 23909871
[TBL] [Abstract][Full Text] [Related]
15. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A
BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837
[TBL] [Abstract][Full Text] [Related]
16. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy.
Hamilos M; Petousis S; Xanthopoulou I; Goudevenos J; Kanakakis J; Sitafidis G; Vavouranakis M; Skalidis E; Kochiadakis G; Lekakis J; Vardas PE; Alexopoulos D
Coron Artery Dis; 2018 Jan; 29(1):53-59. PubMed ID: 28834792
[TBL] [Abstract][Full Text] [Related]
18. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
[TBL] [Abstract][Full Text] [Related]
19. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]